Remove 2020 Remove Clinical Pharmacology Remove Documentation
article thumbnail

COVID-19 has propelled the regulatory industry years ahead

pharmaphorum

And advances in digitalisation could facilitate a move from document-based submissions to data-based submissions, through a cloud platform like the one being developed by Accumulus Synergy. A Timeline of COVID-19 Developments in 2020. Digitizing clinical trials. 3, 101 (2020). 3, 50 (2020). References. 16 Marra, C.,

Vaccines 143
article thumbnail

Episode 573: Ceiling dose of ketorolac for renal colic in the ED

Pharmacy Joe

In 1989, a study in the Journal of Clinical Pharmacology compared 10, 30, and 90 mg of IM ketorolac with placebo in 126 patients with cancer pain. While all doses were more effective than placebo, there was no difference in effectiveness between 10, 30, or 90 mg of IM ketorolac. 165 patients were split evenly between the 3 groups.

article thumbnail

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

Disparities in clinical trial participation have been well-documented, with certain populations, particularly racial and ethnic minorities, women, pregnant and lactating people, older adults, and people with disabilities, often underrepresented in clinical research. Clinical Pharmacology & Therapeutics , 97(3) , 263–273.